Evidence map›Paper›PMID 42210144›Full record

Observational studyBMC geriatrics2026

Mortality and transitions-of-care after COVID-19 hospitalization among US Medicare patients: a retrospective claims analysis.

Alon Yehoshua, Rachel M Black, Anan Zhou, Michelle A Silver, Yu Han, Santiago Mc Lopez, Manuela Di Fusco, Benjamin Yarnoff, Rajeev M Nepal, Maria M Fernandez and 2 more

Abstract readObservational Study
In one paragraph

Observational study in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alon YehoshuaPfizer Inc, New York, NY, USA. alon.yehoshua@pfizer.com.
Rachel M BlackAESARA Inc, Chapel Hill, NC, USA.
Anan ZhouGenesis Research Group, Hoboken, NJ, USA.
Michelle A SilverGenesis Research Group, Hoboken, NJ, USA.
Yu HanGenesis Research Group, Hoboken, NJ, USA.
Santiago Mc LopezPfizer Inc, New York, NY, USA.
Manuela Di FuscoPfizer Inc, New York, NY, USA.
Benjamin YarnoffEvidera Inc, Bethesda, MD, USA.
Rajeev M NepalPfizer Inc, New York, NY, USA.
Maria M FernandezPfizer Inc, New York, NY, USA.
Mohammad Ashraf ChaudharyPfizer Inc, New York, NY, USA.
Tara AhiPfizer Inc, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe patient burden from COVID-19 extends beyond acute hospitalization, especially for older adults. The objective of this study was to describe post-discharge care settings and mortality rates after a COVID-19 hospitalization among adults aged ≥ 65 years in the United States.

methodsThis retrospective observational study used the Medicare fee-for-service dataset. We identified Medicare patients hospitalized with COVID-19 from September 2023-February 2024. The date of discharge was the index date. Patients were followed until death, end of enrollment, or six months post-index. Pre- and post- hospitalization care settings, all-cause mortality, and readmission rates were analyzed. Patients were stratified by COVID-19 severity (general ward, intensive care unit [ICU], invasive mechanical ventilation [IMV]) and age (65-74, ≥ 75 years old).

resultsA total of 67,358 patients were included; most were female (55.6%), white (84.9%), and on average 80.8 years (standard deviation: 8.1). The majority (96.4%) had ≥ 1 high-risk condition as defined by the Centers for Disease Control and Prevention (CDC). The median (interquartile range) length of stay was 5.0 (3.0-7.0) days. During index hospitalization, 4.4% of patients were admitted to the ICU and 5.1% required IMV. Post-discharge, 50.5% of patients who resided at home pre-hospitalization (self-care or under care) required increased care. Less than half (47.8%) of patients who were home (self-care) pre-hospitalization returned home (self-care) upon discharge. A total of 11,658 (17.4%) patients died within 6-months of hospital discharge. Mortality rates increased for patients requiring higher levels of care: 7.1% of patients discharged home (self-care), 13.0% of patients discharged home (under care), and 31.8% discharged to any healthcare facility died within six months. Mortality was higher in those with more severe COVID-19 and those aged ≥ 75 years. The COVID-19-related readmission rate was 4.5% within six months of discharge, and 3.2% occurred within 30 days.

conclusionThe proportion of older adults who lost independence and required care (under care at home or at a healthcare facility) more than doubled after COVID-19 hospitalization, making the post-discharge period a particularly vulnerable time for patients, who are at risk for death and hospital readmission.

Indexed as

COVID-19HospitalizationHospital to Home TransitionMedicareAgedAged, 80 and overFemaleHumansMalePatient DischargePatient ReadmissionRetrospective StudiesUnited StatesCOVID-19MortalityOlder adultsPost-hospitalizationTransitions-of-care

Identifiers

PMID42210144
PMCPMC13412174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.